Asset Allocation

As of November 30, 2025.
Type % Net
Cash 4.18%
Stock 54.63%
Bond 37.24%
Convertible 0.00%
Preferred 0.00%
Other 3.95%
View Asset Allocation
Start Trial

Market Capitalization

As of November 30, 2025
Large 74.25%
Mid 17.49%
Small 8.26%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 92.77%    % Emerging Markets: 0.50%    % Unidentified Markets: 6.73%

Americas 92.03%
88.58%
Canada 0.54%
United States 88.04%
3.45%
Brazil 0.18%
Mexico 0.31%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 1.22%
United Kingdom 0.30%
0.92%
France 0.05%
Germany 0.03%
Ireland 0.46%
Italy 0.01%
Netherlands 0.15%
Switzerland 0.20%
0.00%
0.00%
Greater Asia 0.01%
Japan 0.01%
0.00%
0.00%
Singapore 0.00%
0.00%
Unidentified Region 6.73%

Bond Credit Quality Exposure

AAA 15.60%
AA 23.83%
A 9.22%
BBB 10.71%
BB 4.50%
B 2.06%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 34.07%
Short Term 0.00%
As of November 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
29.56%
Materials
1.06%
Consumer Discretionary
12.98%
Financials
13.76%
Real Estate
1.75%
Sensitive
53.24%
Communication Services
11.76%
Energy
3.78%
Industrials
6.03%
Information Technology
31.66%
Defensive
17.21%
Consumer Staples
4.34%
Health Care
10.57%
Utilities
2.29%
Not Classified
0.00%
Non Classified Equity
0.00%
Not Classified - Non Equity
0.00%
As of November 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of November 30, 2025
Type % Net
Government 0.84%
Corporate 28.75%
Securitized 70.41%
Municipal 0.00%
Other 0.00%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
1.66%
Less than 1 Year
1.66%
Intermediate
28.19%
1 to 3 Years
4.93%
3 to 5 Years
6.76%
5 to 10 Years
16.50%
Long Term
69.46%
10 to 20 Years
10.64%
20 to 30 Years
38.59%
Over 30 Years
20.24%
Other
0.69%
As of November 30, 2025
View Bond Maturity Exposure
Start Trial